This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oxford University Innovation Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mounir Andaloussi: Innovator in Bacterial Infection Treatment
Introduction
Mounir Andaloussi is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target bacterial infections.
Latest Patents
Mounir holds a patent for "Inhibitors of metallo-beta-lactamases." This invention relates to compounds of Formula (I) that function as inhibitors of bacterial metallo-beta-lactamases. The patent also covers processes for the preparation of these compounds, pharmaceutical compositions comprising them, and their use in treating bacterial infections.
Career Highlights
Mounir Andaloussi is associated with Oxford University Innovation Limited, where he applies his expertise in developing innovative solutions for healthcare challenges. His work focuses on creating effective treatments for bacterial infections, which are a growing concern in modern medicine.
Collaborations
Mounir collaborates with talented individuals such as Tharindi Panduwawala and Peter Brandt, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mounir Andaloussi's work in developing inhibitors of metallo-beta-lactamases showcases his commitment to advancing medical science. His contributions are vital in the ongoing battle against bacterial infections, highlighting the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile